Health Promotion and Human Behavior : Kyoto University / 京都大学大学院 医学研究科 社会健康医学系専攻 健康増進・行動学分野

TOPICS

2020.4.XX 新型コロナウイルス感染症への対応において、メンタルケアがさまざまな局面で重要な課題として挙がってきています。いくつかのリソースへのリンクを更新していきたいと思います。
-- COVID-19 & clinical management of mental health issues by Oxford Precision Psychiatry Lab
-- New Webinar Series: Mental Health & COVID-19 by The Lancet Psychiatry, Mental Health Innovation Network, MHPSS.net and United for Global Mental Health
2020.3.24 Due to the COVID-19 pandemic, the open campus for 2021 will be held remotely via web (individual consultation also available). For details, please see our KUSPH homepage
2020.3.20 Prof Furukawa's commentary on Bondar et al's re-analysis of TADS study appeared in this month's Lancet Psychiatry: Furukawa TA (2020) Adolescent depression: from symptoms to individualised treatment? 7, 295-296.
2020.3.17 A network meta-analysis of several attention bias modification interventions for depression and anxiety found one of them may be hopeful: Fodor LA, Georgescu R, Cuijpers P, Szamoskozi S, David D, Furukawa TA & Cristea IA (in press) The effectiveness of cognitive bias modification interventions in anxiety and depressive disorders: a network meta-analysis. Lancet Psychiatry. (IF=18.3)
2020.3.15 A letter to the editor by Dr Hissei Imai (Visiting Researcher) on the lessons learnt from the H1N1 pandemic in Japan was published online in Psychiatry and Clinical Neurosciences: Trust is a key factor in the willingness of health professionals to work during the COVID-19 outbreak: Experience from the H1N1 pandemic in Japan 2009. https://onlinelibrary.wiley.com/doi/full/10.1111/pcn.12995
2020.3.1

Three papers by Prof Furukawa were rated as Hot Papers (top 0.1% of the field in the past 2 years)

-- Furukawa TA, Cipriani A, Cowen PJ, Leucht S, Egger M & Salanti G (2019) Optimal dose of selective serotonin reuptake inhibitors, venlafaxine, and mirtazapine in major depression: a systematic review and dose-response meta-analysis. Lancet Psychiatry, 6, 601-609.

-- Cipriani A, Furukawa TA, Salanti G, Chaimani A, Atkinson LZ, Ogawa Y, Leucht S, Ruhe HG, Turner EH, Higgins JPT, Egger M, Takeshima N, Hayasaka Y, Imai H, Shinohara K, Tajika A, Ioannidis JPA & Geddes JR (2018) Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet, 391, 1357-1366.

-- Brignardello-Petersen R, Bonner A, Alexander PE, Siemieniuk RA, Furukawa TA, Rochwerg B, Hazlewood GS, Alhazzani W, Mustafa RA, Murad MH, Puhan MA, Schunemann HJ & Guyatt GH (2018) Advances in the GRADE approach to rate the certainty in estimates from a network meta-analysis. Journal of Clinical Epidemiology, 93, 36-44.

and further five papers as Highly Cite Papers (top 1% of the field in that year) in the Web of Science.

2020.3.1 Dr Shino Kikuchi's protocol paper for the ongoing randomized controlled trial of CBT for irritable bowel syndrome was published in BMC Gastroenterology (IF=2.3) : Kikuchi S, Oe Y, Sasaki Y, Ishii H, Ito Y, Horikoshi M, Sozu T, Seno H & Furukawa TA (2020) Group cognitive behavioural therapy (GCBT) versus treatment as usual (TAU) in the treatment of irritable bowel syndrome (IBS): a study protocol for a randomized controlled trial. BMC Gastroenterology, 20, 29. https://www.ncbi.nlm.nih.gov/pubmed/32019509
2020.3.1 A narrative review on persistent depressive disorder has been accepted in Lancet Psychiatry (IF=18.3): Schramm E, Klein DN, Elsaesser M, Furukawa TA & Domschke K (in press) Review of dysthymia and persistent depressive disorder: History, correlates and clinical implications.
2020.2.27 Dr. Naotsugu Iwakami (graduate from DrPH course in 2018 and currently visiting researcher) published in Journal of Clinical Epidemiology (IF=4.7): Iwakami N, Nagai T, Furukawa TA, Tajika A, Onishi A, Nishimura K, Ogata S, Nakai M, Takegami M, Nakano H, Kawasaki Y, Alba AC, Guyatt GH, Shiraishi Y, Kohsaka S, Kohno T, Goda A, Mizuno A, Yoshikawa T & Anzai T (2020) Optimal sampling in derivation studies was associated with improved discrimination in external validation for heart failure prognostic models. 121, 71-80.
2020.2.20 A new study based on the GRISELDA showed that personalized medicine appears possible with antidepressants: Maslej MM, Furukawa TA, Cipriani A, Andrews PW & Mulsant BH (2020) Individual Differences in Response to Antidepressants: A Meta-analysis of Placebo-Controlled Randomized Clinical Trials. JAMA Psychiatry (IF=15.9). This is in contrast to antipsychotics.
2020.2.6 Prof Furukawa's letter to the editor appeared in JAMA (IF=51.3), reminding the difference between the MIC (Minimal Imprtant Change) and the SWD (Smallest Worthwhile Difference). We should not directly appraise the SWD, the smallest difference in response between two treatments to choose one over the other, based on the MIC, the minimal change on a specific scale that the patient would find important. The SWD is treatments-specific, while the MIC is scale-specific. Furukawa TA (2020) Measuring Clinical Importance in a Trial of Interventions for Mixed Urinary Incontinence. JAMA, 323, 479.
2020.1.13 Dr Yan Luo (PhD candidate, 2nd year) had a paper accepted by Frontiers in Psychiatry (IF=3.2): Luo Y, Kataoka Y, Ostinelli EG, Cipriani A & Furukawa TA (in press) National prescription patterns of antidepressants in the treatment of adults with major depression in the US between 1996 and 2015.
2020.1.9 A new and comprehensive network meta-analysis comparing psychotherapy, pharmacotherapy and their combination by Prof Cuijpers, Dr Karyotaki and Dr Vinkers (VU Amsterdam), A/Prof Noma (Institute of Statistical Mathematics), Prof Cipriani (U of Oxford) and Prof Furukawa was published in World Psychiatry (IF=34.0). Cuijpers P, Noma H, Karyotaki E, Vinkers CH, Cipriani A & Furukawa TA (2020) A network meta-analysis of the effects of psychotherapies, pharmacotherapies and their combination in the treatment of adult depression. 19, 92-107.
2020.1.1

We have listed our publications in 2019.

Of the 51 publicatioins in English,  15 (29.4%) were in jounals with IF greater than 5, of which 11 (21.2%) were in journals with IF greater than 10.

2019.12.19 Dr Naotsugu Iwakami (Visiting researcher) had the following paper accepted by Annals of Noninvasive Electrocardiology (IF=1.2): Iwakami N, Aiba T, Kamakura S, Takaki H, Furukawa TA, Sato T, Sun W, Shishido T, Nishimura K, Yamada-Inoue Y, Nagase S, Shimizu W, Yasuda S, Sugimachi M & Kusano K (in press) Identification of malignant early repolarization pattern by late QRS activity in high resolution magnetocardiography.
2019.11.14 Dr Satoshi Funada (2nd year PhD candidate), under supervision by A/Prof Tabara, Watanabe, Akamatsu and others, had the following paper accepted by Journal of Urology (IF=5.6): Funada S, Tabara Y, Negoro H, Akamatsu S, Yoshino T, Yoshimura K, Watanabe N, Furukawa TA, Matsuda F, Ogawa O & Nagahama Study Group (in press) Longitudinal analysis of bidirectional relationships between nocturia and depressie symptoms: the Nagahama Study.
2019.11.14 A/Professor Noma (Institute of Statistical Mamethmatics), together with Prof Furukawa and others, published a methodological paper for meta-analysis of diagnostic tests in Research Synthesis Methods (IF=5.0): Noma H, Gosho M, Ishii R, Oba K & Furukawa TA (in press) Influence diagnostics and outlier detection for meta-analysis of diagnostic test accuracy.
2019.10.15 Prof Furukawa and Prof Kessler (Harvard University) has contributed a debate piece to Australiand and New Zeland Journal of Psychiatry (IF=5.0), discussing the hot question "Why has prevalence of mental disorders not decreased as treatment has increased?"
2019.10.5 We received three letters to the editor to our dose-response meta-analysis paper in The Lancet Psychiatry. Our responses to these criticisms appear in: Furukawa TA, Cowen PJ, Salanti G, Leucht S, Egger M & Cipriani A (2019) Optimal dosing of antidepressant drugs - Authors' reply. Lancet Psychiatry, 6, 806-807.
2019.10.5 Dr Ryuhei So (Research Associate)  was awarded 小杉好弘記念賞 from the Japanese Society of Alcohol-Related Problems for his research entitled "The 2-Year Course of Internet Addiction Among a Japanese Adolescent Psychiatric Clinic Sample with ASD and/or ADHD"
2019.10.5 Ms Hwang Chiyoung (3rd year PhD candidate) was awarded 小杉好弘記念賞 from the Japanese Society of Alcohol-Related Problems for her research on gambling disorder among homeless people at selected facilities in Osaka city, Japan.
2019.9.16 Dr Edoardo Ostinelli, visiting researcher from the University of Milan, had the following protocol paper accepted by BMJ Open (IF=2.4): Ostinelli EG, D'Agostino A, Shokraneh F, Salanti G & Furukawa TA (in press) Acute Interventions for Aggression and agitation in psychosiS (AIAS): study protocol for a systematic review and network meta-analysis.
2019.9.4 A new paper was accepted for publication in Drug and Alcohol Dependence (IF=3.5): Sahker E, Ali SR, Arndt S (in press) Employment recovery capital in the treatment of substance use disorders: Six-month follow-up observations.
2019.9.1 We are very pleased to welcome Dr Ethan Sahker (イーサン・サーカー) , PhD in counseling psychology from University of Iowa and University of California San Diego, as JSPS International Fellow in our Department for the coming two years.
2019.8.29 A Cochrane review (IF=7.8) was published under A/Professor Watanabe's supervision: Yamazaki H, So R, Matsuoka K, Kobayashi T, Shinzaki S, Matsuura M, Okabayashi S, Kataoka Y, Tsujimoto Y, Furukawa TA & Watanabe N (2019) Certolizumab pegol for induction of remission in Crohn's disease. Cochrane Database of Systematic Reviews, Art. No.:CD012893.
2019.8.16 Prof Furukawa was nominated the first awardee of Lundbeck Science Award (Clinical Research) of the Asian College of Neuropsychopharmacology (AsCNP). The awarding ceremony will take place during the upcoming 6th Congress of AsCNP in Fukuoka this October 11-13.
2019.7.11 Prof Furukawa's commentary on an interesting new analysis of the influence of baseline severity on antidepressant efficacy by Hieronymus et al (2019) was published in The Lancet Psychiatry: Furukawa TA (2019) Baseline severity and efficacy of antidepressants: into the third generation of research.
2019.7.11 Dr Masafumi Tada had the following protocol paper accepted by BMJ Open (IF=2.4) : Tada M, Azuma H, Yamada N, Kano K, Nagai H, Maeda S, Ishida H, Aoyama T, Okada R, Kawano T, Kobuchi T, Uzui H, Matano H, Iwasaki H, Maeno K, Shimada Y, Yoshida H, Ando M, Murakami Y, Iwakami N, Kishimoto S, Iwami T, Tada H, Chapman AR, Mills NL, Hayashi H, Furukawa TA & Watanabe N (in press) A comprehensive validation of very early rule-out strategies for non-ST-segment elevation myocardial infarction in emergency departments: protocol for a multicenter prospective cohort study.
2019.7.5 Dr Tadashi Kato (Aratama Kokorono Clinic) was awarded the prestigious Shimoda Mitsuzo Prize for the primary paper from the SUN(^_^)D trial, published last year in BMC Medicine.
2019.7.3 Dr Shino Kikuchi was awarded a continued research grant from Mental Health Okamoto Foundation for her RCT of CBT for irritable bowel syndrome.
Dr Hissei Imai was awarded a research grant from Mental Health Okamoto Foundation for his prospective study of Hikikomori.
And Dr Ryuhei So was awarded a research grant from Mental Health Okamoto Foundation for his case vignette study with registered psychiatrists.

2019.6.6 Profs Furukawa and Salanti's dose-response meta-analysis, published online today by The Lancet Psychiatry, was featured in Asahi Shimbun.
2019.6.6 Ms Hwang Chiyoung was awarded 京都大学教育研究振興財団国際研究集会発表助成.
2019.6.3 Professor Georgia Salanti (University of Bern) and Professor Yannis Michopoulos (University of Athens) have arrived in our department for two and three, respectively, months of fun and fruitful collaborative research! We are very grateful to JSPS and Matsumae Foundation, again respectively, who have enabled such important opportunities.
2019.6.1 A long-overdue review from our department was finally published in the Cochrane Library: Ogawa Y, Takeshima N, Hayasaka Y, Tajika A, Watanabe N, Streiner D & Furukawa TA (2019) Antidepressants plus benzodiazepines for adults with major depression. Cochrane Database of Systematic Reviews, Art. No.: CD001026.
2019.5.31 The first systematic review of specific somatic SAEs due to antipsychotics was accepted in the Lancet Psychiatry (IF=15.2): Schneider-Thoma J, Efthimiou O, Bighelli I, Dörries C, Huhn M, Krause M, Reichelt L, Röder H, Furukawa TA, Davis JM & Leucht S (in press) Second-generation antipsychotic drugs and short-term somatic serious adverse events: a systematic review and meta-analysis of placebo-controlled randomised controlled trials.
2019.5.9 A dose-response meta-analysis of new generation antidepressants was accepted in the Lancet Psychiatry (IF=15.2): Furukawa TA, Cipriani A, Cowen PJ, Leucht S, Egger M & Salanti G (in press) Optimal dose of selective serotonin reuptake inhibitors, venlafaxine and mirtazapine in major depression: Systematic review and dose-response meta-analysis.
2019.4.18 Professor Furukawa was awarded The Best Teacher's Award for the academic year 2018 in KUSPH. He would like to thank all the students who judged that they could learn the most from his lectures!
2019.4.10 A new review was published in Cochrane Database of Systematic Reviews (IF=6.8): Breilmann J, Girlanda F, Guaiana G, Barbui C, Cipriani A, Castellazzi M, Bighelli I, Davies JC, Furukawa TA & Koesters M (2019) Benzodiazepines versus placebo for panic disorder in adults. Cochrane Database of Systematic Reviews, Art. No.: CD010677.
2019.3.30 Dr. Naotsugu Iwakami (graduate from DrPH course in 2018 and currently visiting researcher) received the 36th Young Investigator's Award for "Clinical Research" from The Japanese Circulation Society for his paper ''Optimal Sampling in Derivation Studies Determines Performance of Heart Failure Prognostic Models."
2019.2.8 The following paper was accepted by Epidemiology and Psychiatric Sciences (IF=5.7): Furukawa TA, Reijnders M, Kishimoto S, Sakata M, DeRubeis RJ, Dimidjian S, Dozois DJ, Hegerl U, Hollon SD, Jarrett RB, Lesperance F, Segal ZV, Mohr DC, Simons AD, Quilty LC, Reynolds CFI, Gentili C, Leucht S, Engel RR & Cuijpers P (in press) Translating the BDI and BDI-II into the HAMD and vice versa with equipercentile linking.
2019.1.27 The following paper has now been accepted by JAMA Psychiatry (IF=16.6): Cuijpers P, Noma H, Karyotaki E, Cipriani A & Furukawa TA (in press) Individual, group, telephone, self-help and internet-based cognitive behavior therapy for adult depression: A network meta-analysis of delivery methods.
2019.1.24 Professor Fururkawa has been invited to serve on the Editorial Advisory Board of The Lancet Psychiatry.
2019.1.21

Web of Science rated seven papers by Prof Furukawa as Highly Cited Papers (top 1 % in the academic field) and two papers as Hot Papers (top 0.1% in the academic field within the past two years).

HIGHLY CITED PAPERS

-- Cipriani A, Furukawa TA, Salanti G, Geddes JR, Higgins JP, Churchill R, Watanabe N, Nakagawa A, Omori IM, McGuire H, Tansella M & Barbui C (2009) Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. Lancet, 373, 746-758.

-- Kessler RC, Green JG, Gruber MJ, Sampson NA, Bromet E, Cuitan M, Furukawa TA, Gureje O, Hinkov H, Hu CY, Lara C, Lee S, Mneimneh Z, Myer L, Oakley-Browne M, Posada-Villa J, Sagar R, Viana MC & Zaslavsky AM (2010) Screening for serious mental illness in the general population with the K6 screening scale: results from the WHO World Mental Health (WMH) survey initiative. International Journal of Methods in Psychiatric Research, 19 Suppl 1, 4-22.

-- Furukawa TA, Kawakami N, Saitoh M, Ono Y, Nakane Y, Nakamura Y, Tachimori H, Iwata N, Uda H, Nakane H, Watanabe M, Naganuma Y, Hata Y, Kobayashi M, Miyake Y, Takeshima T & Kikkawa T (2008) The performance of the Japanese version of the K6 and K10 in the World Mental Health Survey Japan. International Journal of Methods in Psychiatric Research, 17, 152-158.

-- Guyatt GH, Thorlund K, Oxman AD, Walter SD, Patrick D, Furukawa TA, Johnston BC, Karanicolas P, Akl EA, Vist G, Kunz R, Brozek J, Kupper LL, Martin SL, Meerpohl JJ, Alonso-Coello P, Christensen R & Schunemann HJ (2013) GRADE guidelines: 13. Preparing Summary of Findings tables and evidence profiles-continuous outcomes. Journal of Clinical Epidemiology, 66, 173-183.

-- Miura T, Noma H, Furukawa TA, Mitsuyasu H, Tanaka S, Stockton S, Salanti G, Motomura K, Shimano-Katsuki S, Leucht S, Cipriani A, Geddes JR & Kanba S (2014) Comparative efficacy and tolerability of pharmacological treatments in the maintenance treatment of bipolar disorder: A network meta-analysis. Lancet Psychiatry, 1, 351-359.

-- Cipriani A, Furukawa TA, Salanti G, Chaimani A, Atkinson LZ, Ogawa Y, Leucht S, Ruhe HG, Turner EH, Higgins JPT, Egger M, Takeshima N, Hayasaka Y, Imai H, Shinohara K, Tajika A, Ioannidis JPA & Geddes JR (2018) Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet, 391, 1357-1366.

-- Brignardello-Petersen R, Bonner A, Alexander PE, Siemieniuk RA, Furukawa TA, Rochwerg B, Hazlewood GS, Alhazzani W, Mustafa RA, Murad MH, Puhan MA, Schunemann HJ & Guyatt GH (2018) Advances in the GRADE approach to rate the certainty in estimates from a network meta-analysis. Journal of Clinical Epidemiology, 93, 36-44.

 

HOT PAPER

-- Cipriani A, Furukawa TA, Salanti G, Chaimani A, Atkinson LZ, Ogawa Y, Leucht S, Ruhe HG, Turner EH, Higgins JPT, Egger M, Takeshima N, Hayasaka Y, Imai H, Shinohara K, Tajika A, Ioannidis JPA & Geddes JR (2018) Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet, 391, 1357-1366.

-- Brignardello-Petersen R, Bonner A, Alexander PE, Siemieniuk RA, Furukawa TA, Rochwerg B, Hazlewood GS, Alhazzani W, Mustafa RA, Murad MH, Puhan MA, Schunemann HJ & Guyatt GH (2018) Advances in the GRADE approach to rate the certainty in estimates from a network meta-analysis. Journal of Clinical Epidemiology, 93, 36-44.

2019.1.1

We have listed our publications in 2018.

Of the 51 English papers published in 2018, 8 (15.6%) had an impact factor above 10, and 17 (33.3%) had an impact factor above 5.

ADDRESS

Health Promotion and Human Behavior, Kyoto University Graduate School of Medicine / School of Public Health
Yoshida Konoe-cho, Sakyo-ku, Kyoto 606-8501 JAPAN
TEL:+81-75-753-9491 FAX:+81-75-753-4641

Copyright© 2010-19 Health Promotion and Human Behavior, Kyoto University. All Rights Reserved.
Top of Page